Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,007 | -113,012 | -192,036 | -91,130 | -27,474 |
| Depreciation Amortization | 770 | 8,830 | 1,578 | 763 | 726 |
| Accounts receivable | 259 | -125 | 288 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,429 | -1,194 | 216 | 3,200 | 185 |
| Other Working Capital | -3,424 | -7,686 | 8,824 | -951 | 640 |
| Other Operating Activity | 13,591 | 13,051 | 9,746 | 1,094 | 1,597 |
| Operating Cash Flow | $-53,240 | $-100,136 | $-171,384 | $-87,024 | $-24,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -486 | -1,615 | -2,866 | -8,201 | -578 |
| Investing Cash Flow | $-486 | $-1,615 | $-2,866 | $-8,201 | $-578 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Common Stock Issued | 33 | 406 | 234,429 | 16 | 19 |
| Other Financing Activity | 0 | 0 | 0 | 246,738 | 24,594 |
| Financing Cash Flow | $33 | $406 | $234,429 | $246,754 | $39,613 |
| Beginning Cash Position | 131,967 | 233,312 | 173,133 | 21,604 | 6,895 |
| End Cash Position | 78,274 | 131,967 | 233,312 | 173,133 | 21,604 |
| Net Cash Flow | $-53,693 | $-101,345 | $60,179 | $151,529 | $14,709 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,240 | -100,136 | -171,384 | -87,024 | -24,326 |
| Capital Expenditure | -486 | -1,615 | -2,866 | -8,201 | -578 |
| Free Cash Flow | -53,726 | -101,751 | -174,250 | -95,225 | -24,904 |